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ABSTRACT 
 
Drug Utilization Study in Stevens Johnson  
Syndrome Patients 
(Study at Department of Dermato-Venereology dr. 
Soetomo Teaching Hospital Surabaya) 
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Stevens Johnson Syndrome (SJS) is an erythema multiforme 
variant, a condition of rare acute mucocutaneous that is caused by 
hypersensitivity reaction. Pathogenesis SJS is estimated as hypersensitivity 
type III or type IV or the combination of both. SJS is caused by some 
medicines allergic, infection, vaccination, infectious diseases or idiopathic. 
This study was aimed to examine the drug utilization patterns for patients 
including type of drugs, dosage, route of administration, frequency and 
duration of use and identify the drug related problems. This study was done 
retrospectively for period 1st January 2014 to 31th December 2017 and 
analyzed by descriptive method. This study was reviewed and ethically 
approved by the Dr. Soetomo Ethical Committee. There were 22 samples 
included in the study. The results showed that the medicines used by SJS 
patients were corticosteroids (dexamethasone and methylprednisolone), 
antibiotics (gentamicin, cefotaxime and ceftriaxone), antipyretics, 
antihistamine, eye drops, topical for mouth, skin and genitals. Paracetamol 
and carbamazepine were common cause of SJS. Monitoring of drug 
utilization needs to be controlled so that therapeutic targets can be achieved 
more quickly with minimal drug related problems. 
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